Medical News

RSS

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls.

16 Dec 2010

Study reveals immune cell provides new therapeutic strategy for SLE

A new study provides fascinating insight into the underlying pathology associated with the autoimmune disease, systemic lupus erythematosus.

16 Dec 2010

Foster care standards formulated

Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child’s requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.

16 Dec 2010

Asbestos removal from schools poorly handled

Queensland government’s builder - QBuild’s handling of asbestos at a north Queensland school is inappropriate says a report. After a painter at the Mackay West State School identified asbestos in December 2009, the QBuild workers came in to decontaminate the area but they did not wear protective clothing and removed dust with a domestic vacuum cleaner.

16 Dec 2010

Genetic breakthrough in lung cancer

For the study the team studied samples of lung tumors and nearby healthy lung tissue from 30 patients and examined the samples for the presence of messenger ribonucleic acid (mRNA) associated with 48 known genes for molecules called nuclear hormone receptors. Then they compared the active genes with patient outcomes and found that the expression of genes for certain nuclear hormone receptors helped predict patient survival.

16 Dec 2010

Recent mergers and acquisitions in the ultrasound market

The recent shake-up of the global ultrasound market following the merger of Aloka and Hitachi Medical, and the recently announced acquisition of Medison by Samsung Electronics, points to an intriguing future. Research Analyst Stephen Holloway, author of InMedica’s acclaimed “World Market for Ultrasound Imaging Equipment – 2010 edition” assesses the repercussions.

16 Dec 2010

Gene variant linked to liver cirrhosis in Caucasians

A new study by German researchers found that a variation in the PNPLA3 (adiponutrin) gene was associated with cirrhosis of the liver and elevated transaminase (liver enzyme) levels in alcoholic Caucasians. The risk of cirrhosis in alcoholics in the genetic high risk group might be as high as 25 to 50%. Full findings are published in the January 2011 issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

16 Dec 2010

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

16 Dec 2010

Stem cell therapy gives sight to four year old

Izabelle Evans, only four years of age, was born blind but in a medical miracle has been given sight. After a stem cell treatment in China she can see. Her parents James Evans and Hollie McHugh are “over the moon” that their daughter can finally see them. As of now she can see only 3ft away. The treatment that cost the family £50,000.

16 Dec 2010

Quarter of all British school children obese: Report

A quarter of all British school children are obese and by the final year of primary school, the proportion rises to a third. Experts believe that this is not even the actual figure because many children opt out of being weighed. Urban children were much more likely to be overweight than those living in more rural areas.

16 Dec 2010

Some cancers more prevalent in the wealthy

A new report has shown that Australians living in wealthy areas are more likely to get breast, prostate and skin cancers than those living in poorer zones. The report from Australian Institute of Health and Welfare, released yesterday also shows that those living in disadvantaged parts of the country are more likely to have bowel, cervical and lung cancers. Not so much with bowel cancer, but lung cancer incidence varied to a large extent. Main results showed;

16 Dec 2010

HIV patient cured!

German researchers working with stem cell therapy have claimed they have cured an American patient with HIV and leukemia. Experts are wary of accepting the development at its face value and caution that there is a need for further research. Dr David Scadden, a co-director of the Harvard University Stem Cell Institute added, “Cured is a strong word. But this is very encouraging… from all indications, there was no residual virus… It’s as good an outcome as one could hope for.”

16 Dec 2010

Akonni receives $150,000 Phase I NSF grant to assess feasibility of developing lab-on-a-film microarray device

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.

16 Dec 2010

Genome is one more factor to blame for unwanted pounds

In addition to fast food, desk jobs, and inertia, there is one more thing to blame for unwanted pounds-our genome, which has apparently not caught up with the fact that we no longer live in the Stone Age.

16 Dec 2010

Manhattan Pharmaceuticals reports preliminary results from AST-915 Phase 1/2 study in essential tremor

Manhattan Pharmaceuticals, Inc. announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor. Data from this single dose study demonstrated that AST-915 was safe and well tolerated and demonstrated a clear effect on tremor power.

16 Dec 2010

Web-based screening tools for determining TBI or PTS among military service members

Military service members from the Iraq and Afghanistan wars attending this week's 6th annual Road to Recovery Conference and Tribute at Walt Disney World are being given access to two web-based screening tools that enable them to quickly and confidentially determine if they might have suffered a Traumatic Brain Injury (TBI) or have Post-Traumatic Stress (PTS). The three day event is being co-presented by the Coalition to Salute America's Heroes and The American Legion.

16 Dec 2010

GSK to deploy BioClinica's Trident IWR system across Phase I-IV clinical trials

BioClinica®, Inc.,, a global provider of clinical trial management services, today announced that GlaxoSmithKline LLC ("GSK") has signed a multi-year enterprise technology agreement to deploy BioClinica's Trident IWR (Interactive Web Response) system across its Phase I-IV clinical trials.

From Clario 16 Dec 2010

Discovery Labs awarded NIH Fast Track SBIR grant for developing aerosolized KL4 surfactant for RDS

Discovery Laboratories, Inc. today announced that the Company has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to support the development of the Company's program for aerosolizing KL4 surfactant for neonatal respiratory distress syndrome (RDS).

16 Dec 2010

RFA highly valuable therapy for controlling cancerous nodules

16 Dec 2010

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.

16 Dec 2010

Medical News

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Study reveals immune cell provides new therapeutic strategy for SLE

Foster care standards formulated

Asbestos removal from schools poorly handled

Genetic breakthrough in lung cancer

Recent mergers and acquisitions in the ultrasound market

Gene variant linked to liver cirrhosis in Caucasians

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Stem cell therapy gives sight to four year old

Quarter of all British school children obese: Report

Some cancers more prevalent in the wealthy

HIV patient cured!

Akonni receives $150,000 Phase I NSF grant to assess feasibility of developing lab-on-a-film microarray device

Genome is one more factor to blame for unwanted pounds

Manhattan Pharmaceuticals reports preliminary results from AST-915 Phase 1/2 study in essential tremor

Web-based screening tools for determining TBI or PTS among military service members

GSK to deploy BioClinica's Trident IWR system across Phase I-IV clinical trials

Discovery Labs awarded NIH Fast Track SBIR grant for developing aerosolized KL4 surfactant for RDS

RFA highly valuable therapy for controlling cancerous nodules

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News